APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dual Orexin Receptor Antagonist Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dual Orexin Receptor Antagonist Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025173 pages

Choose your research edition.

Industry ResearchDual Orexin Receptor Antagonist Tablets Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Dual Orexin Receptor Antagonist Tablets Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dual Orexin Receptor Antagonist Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dual Orexin Receptor Antagonist Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dual Orexin Receptor Antagonist Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dual Orexin Receptor Antagonist Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dual Orexin Receptor Antagonist Tablets include Idorsia, Merck and Eisal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dual Orexin Receptor Antagonist Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dual Orexin Receptor Antagonist Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dual Orexin Receptor Antagonist Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dual Orexin Receptor Antagonist Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Dual Orexin Receptor Antagonist Tablets Segment by Company

Idorsia

Merck

Eisal

Dual Orexin Receptor Antagonist Tablets Segment by Type

5mg per Tablet

25mg per Tablet

20mg per Tablet

15mg per Tablet

10mg per Tablet

Dual Orexin Receptor Antagonist Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Dual Orexin Receptor Antagonist Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dual Orexin Receptor Antagonist Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dual Orexin Receptor Antagonist Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dual Orexin Receptor Antagonist Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dual Orexin Receptor Antagonist Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dual Orexin Receptor Antagonist Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dual Orexin Receptor Antagonist Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dual Orexin Receptor Antagonist Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dual Orexin Receptor Antagonist Tablets Industry Trends Table 2. Dual Orexin Receptor Antagonist Tablets Industry Drivers Table 3. Dual Orexin Receptor Antagonist Tablets Industry Opportunities and Challenges Table 4. Dual Orexin Receptor Antagonist Tablets Industry Restraints Table 5. Global Dual Orexin Receptor Antagonist Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dual Orexin Receptor Antagonist Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Manufacturers Table 9. Global Dual Orexin Receptor Antagonist Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dual Orexin Receptor Antagonist Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dual Orexin Receptor Antagonist Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dual Orexin Receptor Antagonist Tablets Manufacturers, Product Type & Application Table 13. Global Dual Orexin Receptor Antagonist Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dual Orexin Receptor Antagonist Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5mg per Tablet Table 17. Major Manufacturers of 25mg per Tablet Table 18. Major Manufacturers of 20mg per Tablet Table 19. Major Manufacturers of 15mg per Tablet Table 20. Major Manufacturers of 10mg per Tablet Table 21. Global Dual Orexin Receptor Antagonist Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (K Units) Table 23. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2027-2032) & (K Units) Table 24. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Type (2021-2026) Table 25. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Type (2027-2032) Table 26. Global Dual Orexin Receptor Antagonist Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2021-2026) & (K Units) Table 28. Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2027-2032) & (K Units) Table 29. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Type (2021-2026) Table 30. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital and Clinic Table 32. Major Manufacturers of Retail Pharmacies Table 33. Major Manufacturers of Other Table 34. Global Dual Orexin Receptor Antagonist Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (K Units) Table 36. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2027-2032) & (K Units) Table 37. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Application (2021-2026) Table 38. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Application (2027-2032) Table 39. Global Dual Orexin Receptor Antagonist Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2021-2026) & (K Units) Table 41. Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2027-2032) & (K Units) Table 42. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Application (2021-2026) Table 43. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Application (2027-2032) Table 44. Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2021-2026) & (K Units) Table 46. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Region (2021-2026) Table 47. Global Dual Orexin Receptor Antagonist Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Dual Orexin Receptor Antagonist Tablets Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 51. North America Dual Orexin Receptor Antagonist Tablets Sales by Country (2027-2032) & (K Units) Table 52. Europe Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 54. Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (2027-2032) & (K Units) Table 61. Global Dual Orexin Receptor Antagonist Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Dual Orexin Receptor Antagonist Tablets Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Dual Orexin Receptor Antagonist Tablets Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Region (2021-2026) Table 65. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Region (2027-2032) Table 66. Idorsia Company Information Table 67. Idorsia Business Overview Table 68. Idorsia Dual Orexin Receptor Antagonist Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Idorsia Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 70. Idorsia Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Dual Orexin Receptor Antagonist Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Merck Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 75. Merck Recent Development Table 76. Eisal Company Information Table 77. Eisal Business Overview Table 78. Eisal Dual Orexin Receptor Antagonist Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Eisal Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 80. Eisal Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Dual Orexin Receptor Antagonist Tablets Distributors List Table 84. Dual Orexin Receptor Antagonist Tablets Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Dual Orexin Receptor Antagonist Tablets Product Image Figure 2. Global Dual Orexin Receptor Antagonist Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dual Orexin Receptor Antagonist Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Dual Orexin Receptor Antagonist Tablets Sales (2021-2032) & (K Units) Figure 5. Global Dual Orexin Receptor Antagonist Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dual Orexin Receptor Antagonist Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5mg per Tablet Image Figure 9. 25mg per Tablet Image Figure 10. 20mg per Tablet Image Figure 11. 15mg per Tablet Image Figure 12. 10mg per Tablet Image Figure 13. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Type (2021-2032) Figure 16. Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Type (2021-2032) Figure 19. Hospital and Clinic Image Figure 20. Retail Pharmacies Image Figure 21. Other Image Figure 22. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Application (2021-2032) Figure 25. Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Application (2021-2032) Figure 28. North America Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2032) Figure 30. U.S. Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2032) Figure 35. Germany Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2032) Figure 42. China Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2032) Figure 50. Brazil Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Dual Orexin Receptor Antagonist Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Dual Orexin Receptor Antagonist Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032) & (US$ Million) Figure 61. North America Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Europe Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Dual Orexin Receptor Antagonist Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Dual Orexin Receptor Antagonist Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg per Tablet
  • 25mg per Tablet
  • 20mg per Tablet
  • 15mg per Tablet
  • 10mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Idorsia
  • Merck
  • Eisal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dual Orexin Receptor Antagonist Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dual Orexin Receptor Antagonist Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dual Orexin Receptor Antagonist Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dual Orexin Receptor Antagonist Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dual Orexin Receptor Antagonist Tablets Market Dynamics
  1. 2.1 Dual Orexin Receptor Antagonist Tablets Industry Trends
  2. 2.2 Dual Orexin Receptor Antagonist Tablets Industry Drivers
  3. 2.3 Dual Orexin Receptor Antagonist Tablets Industry Opportunities and Challenges
  4. 2.4 Dual Orexin Receptor Antagonist Tablets Industry Restraints
3 Dual Orexin Receptor Antagonist Tablets Market by Manufacturers
  1. 3.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dual Orexin Receptor Antagonist Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dual Orexin Receptor Antagonist Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dual Orexin Receptor Antagonist Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dual Orexin Receptor Antagonist Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Dual Orexin Receptor Antagonist Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dual Orexin Receptor Antagonist Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dual Orexin Receptor Antagonist Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dual Orexin Receptor Antagonist Tablets Tier 1, Tier 2, and Tier 3
4 Dual Orexin Receptor Antagonist Tablets Market by Type
  1. 4.1 Dual Orexin Receptor Antagonist Tablets Type Introduction
  2. 4.1.1 5mg per Tablet
  3. 4.1.2 25mg per Tablet
  4. 4.1.3 20mg per Tablet
  5. 4.1.4 15mg per Tablet
  6. 4.1.5 10mg per Tablet
  7. 4.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Type
  8. 4.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2032)
  10. 4.2.3 Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Type (2021-2032)
  11. 4.3 Global Dual Orexin Receptor Antagonist Tablets Revenue by Type
  12. 4.3.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Type (2021-2032)
  14. 4.3.3 Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Type (2021-2032)
5 Dual Orexin Receptor Antagonist Tablets Market by Application
  1. 5.1 Dual Orexin Receptor Antagonist Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Application
  6. 5.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Dual Orexin Receptor Antagonist Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dual Orexin Receptor Antagonist Tablets Revenue by Application
  10. 5.3.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Application (2021-2032)
6 Global Dual Orexin Receptor Antagonist Tablets Sales by Region
  1. 6.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region
  1. 7.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region
  2. 7.1.1 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Dual Orexin Receptor Antagonist Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032)
  8. 7.2.2 North America Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dual Orexin Receptor Antagonist Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Idorsia
  2. 8.1.1 Idorsia Company Information
  3. 8.1.2 Idorsia Business Overview
  4. 8.1.3 Idorsia Dual Orexin Receptor Antagonist Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Idorsia Dual Orexin Receptor Antagonist Tablets Product Portfolio
  6. 8.1.5 Idorsia Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Dual Orexin Receptor Antagonist Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Dual Orexin Receptor Antagonist Tablets Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Eisal
  14. 8.3.1 Eisal Company Information
  15. 8.3.2 Eisal Business Overview
  16. 8.3.3 Eisal Dual Orexin Receptor Antagonist Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eisal Dual Orexin Receptor Antagonist Tablets Product Portfolio
  18. 8.3.5 Eisal Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dual Orexin Receptor Antagonist Tablets Value Chain Analysis
  2. 9.1.1 Dual Orexin Receptor Antagonist Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dual Orexin Receptor Antagonist Tablets Production Mode & Process
  6. 9.2 Dual Orexin Receptor Antagonist Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dual Orexin Receptor Antagonist Tablets Distributors
  9. 9.2.3 Dual Orexin Receptor Antagonist Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst